Pacira BioSciences (PCRX) Capital Expenditures (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Capital Expenditures of $1.4 million for Q1 2026, up 77.57% year-over-year from $767000.0 in Q1 2025, and up 524.77% quarter-over-quarter from $218000.0 in Q4 2025.
Pacira BioSciences (PCRX) Capital Expenditures (2010 - 2026) Analysis & Trends
Pacira BioSciences' Capital Expenditures history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Capital Expenditures rose 77.57% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $15.9 million (up 178.22% YoY), while the FY2025 annual figure was $15.3 million, up 175.53% from the prior year.
- Capital Expenditures for Q1 2026 stood at $1.4 million, up from $218000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $13.7 million in Q4 2023, with the low at -$3.0 million in Q4 2024.
- The 5-year median for Capital Expenditures is $3.8 million (2024), against an average of $4.0 million.
- Peak annual rise in Capital Expenditures reached 2708.09% in 2024, while the deepest fall reached 121.57% in 2024.
- Pacira BioSciences' Capital Expenditures stood at $5.5 million in 2022, then soared by 149.29% to $13.7 million in 2023, then slumped by 121.57% to -$3.0 million in 2024, then jumped by 107.38% to $218000.0 in 2025, then jumped by 524.77% to $1.4 million in 2026.
- Business Quant data shows PCRX's Capital Expenditures at $1.4 million in Q1 2026, $218000.0 in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34 Mn |
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.36 Mn |
| Mar 31, 2026 | 1.36 Mn |
| Dec 31, 2025 | 218,000.00 |
| Dec 31, 2025 | 218,000.00 |
| Sep 30, 2025 | 3.87 Mn |
| Sep 30, 2025 | 3.87 Mn |
| Jun 30, 2025 | 10.48 Mn |
| Jun 30, 2025 | 10.48 Mn |
| Mar 31, 2025 | 767,000.00 |
| Mar 31, 2025 | 767,000.00 |
| Dec 31, 2024 | -2.95 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Sep 30, 2024 | 4.09 Mn |
| Sep 30, 2024 | 4.09 Mn |
| Jun 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 3.82 Mn |
| Mar 31, 2024 | 607,000.00 |
| Mar 31, 2024 | 607,000.00 |